
Sign up to save your podcasts
Or


Todd Harris, CEO of Tyra Biosciences, shares his insights about leadership in biopharma and how Tyra is working to develop precision medicines that target large fibroblast growth factor receptor biology.
By John Simboli5
77 ratings
Todd Harris, CEO of Tyra Biosciences, shares his insights about leadership in biopharma and how Tyra is working to develop precision medicines that target large fibroblast growth factor receptor biology.

3,075 Listeners

1,967 Listeners

1,093 Listeners

2,354 Listeners

948 Listeners

797 Listeners

124 Listeners

337 Listeners

6,089 Listeners

92 Listeners

10,182 Listeners

576 Listeners

149 Listeners

248 Listeners

188 Listeners